Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

An Update on Pharmacologic Management of Neonatal Hypotension

When, Why, and Which Medication

Bibliographic Data

ID15712941
AuthorsEleni Agakidou (0000-0001-7361-0510, Aristotle University of Thessaloniki, corresponding author), Ilias Chatziioannidis (0000-0002-5570-9514, Aristotle University of Thessaloniki), Angeliki Kontou (0000-0002-9961-9537, Aristotle University of Thessaloniki), Theodora Stathopoulou (0009-0008-6770-0542, Aristotle University of Thessaloniki), William Chotas (University of Vermont), Kosmas Sarafidis (0000-0002-6806-6343, Aristotle University of Thessaloniki)
Year2024
Volume11
Issue4
Pages490-490
Publication date2024-04-19
Open AccessYes
TypeARTICLE
VenueChildren (JOURNAL)
Journal identifiersISSN: 2227-9067 • E-ISSN: 2227-9067
PublisherMultidisciplinary Digital Publishing Institute (PUBLISHER • CH)
DOI10.3390/children11040490
PMID38671707
OpenAlexW4394953272
LanguageEN
Citations received1
References cited241

Anti-hypotensive treatment, which includes dopamine, dobutamine, epinephrine, norepinephrine, milrinone, vasopressin, terlipressin, levosimendan, and glucocorticoids, is a long-established intervention in neonates with arterial hypotension (AH). However, there are still gaps in knowledge and issues that need clarification. The main questions and challenges that neonatologists face relate to the reference ranges of arterial blood pressure in presumably healthy neonates in relation to gestational and postnatal age; the arterial blood pressure level that potentially affects perfusion of critical organs; the incorporation of targeted echocardiography and near-infrared spectroscopy for assessing heart function and cerebral perfusion in clinical practice; the indication, timing, and choice of medication for each individual patient; the limited randomized clinical trials in neonates with sometimes conflicting results; and the sparse data regarding the potential effect of early hypotension or anti-hypotensive medications on long-term neurodevelopment. In this review, after a short review of AH definitions used in neonates and existing data on pathophysiology of AH, we discuss currently available data on pharmacokinetic and hemodynamic effects, as well as the effectiveness and safety of anti-hypotensive medications in neonates. In addition, data on the comparisons between anti-hypotensive medications and current suggestions for the main indications of each medication are discussed

Anesthesia · Blood pressure · Cardiology · Clinical trial · Dobutamine · Hemodynamics · Inotrope · Intensive care medicine · Levosimendan · Milrinone · Terlipressin · Vasopressin · Cardiovascular Conditions and Treatments · Mechanical Circulatory Support Devices · Medicine · Neonatal Respiratory Health Research · Internal Medicine

  • Sodium Patterns and Their Variables in a Cohort of ELBW Infants in the First 10 Days of Life

    Open Access•Stijn van Sas, Myrna Pace et al.•Children•2025

  • Association of Plasma Cortisol Levels with Gestational Age and Anthropometric Values at Birth in Preterm Infants

    Open Access•Masako Aoki, Tatsuhiko Urakami et al.•International Journal of…•2022

Citations per year1
Citation span2025 - 2025 (1)
Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae